Independent evaluation confirms IFFIm success
Independent evaluation confirms IFFIm success
1 July 2011
HLSP analysis finds IFFIm transformative and a 'strong case for further investment'
IFFIm saves many additional lives and money, and has helped "transform GAVI from a niche actor into a major player in international health." That's the conclusion of a well-respected, independent health care consulting firm in a new, independent evaluation of IFFIm, noting that the programme should be expanded.
"This evaluation positively affirms what we have long known: IFFIm is a success," said Alan Gillespie, Chair of the IFFIm Board of Directors.
"IFFIm raises capital efficiently, makes good use of frontloading and is a strong vehicle for further donor investment."
"This evaluation positively affirms what we have long known: IFFIm is a success," said Chair of the IFFIm Board of Directors, Alan Gillespie.
Low-cost, efficient model
The evaluation, by London-based HLSP and commissioned by GAVI at the request of the IFFIm board of directors, describes the model under which IFFIm operates as "proven" to be a low-cost, efficient way to help achieve the UN Millennium Development Goals by improving global health and achieving predictability in global health funding.
The report also notes that IFFIm can be credited with saving at least 2.75 million lives.
Case for further investment
"The case for further investment through IFFIm is strong," HLSP notes, adding that IFFIm's funding and liquidity have been "managed extremely well" by its treasury manager, the World Bank.
"IFFIm funds have been spent on activities which have delivered, or seem likely to deliver, extremely good development returns," HLSP adds.
HLSP estimates that - under the most conservative analysis - IFFIm's benefit-cost ratio is at least 3.5:1, meaning that it delivers more than three times the value of each dollar spent. And given that GAVI has achieved this under "extremely difficult settings" in the poorest nations, HLSP notes that the benefit-cost ratio could be as high as 19.5:1.
Force for innovation
"GAVI has been a force for innovation with IFFIm, cost-effectively delivering additional funding for immunisation," Gunilla Carlsson, the Minister for International Development Cooperation for Sweden, said at GAVI's 13 June 2011 pledging conference.
Sweden is one of IFFIm's donors, who collectively responded to the evaluation. Others that provided responses were the IFFIm board, GAVI and the World Bank.
Frontloading
The HLSP evaluation is highly complimentary of the IFFIm model, which significantly increases aid flows through frontloading. This gives IFFIm the ability to "time shift" funds, offering GAVI flexibility in its programming and recipients predictability that spurs the scale-up of widespread immunisation.
"IFFIm provides developing countries with predictable aid flows for immunisation," explains Susan McAdams, who oversees the World Bank's relationship with IFFIm.
HLSP commends the World Bank's involvement in as treasury manager for IFFIm and its contribution toward keeping funding below the weighted average of rates paid by IFFIm's donors.
"Overall, IFFIm has traded at a small premium to the World Bank and, in recent times, below the spread for the EIB and KfW - an impressive achievement," the consulting firm says, referring to the European Investment Bank and the large German development bank.
Download IFFIm evaluation documents
IFFIm evaluation: executive summary
IFFIm evaluation: GAVI Secretariat response
IFFIm evaluation: IFFIm Board response
IFFIm evaluation: IFFIm donor response
IFFIm evaluation: key messages
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.